Follow
Karen Hodgson
Karen Hodgson
Public Health Wales
Verified email at wales.nhs.uk
Title
Cited by
Cited by
Year
Genetic differences in cytochrome P450 enzymes and antidepressant treatment response
K Hodgson, K Tansey, MZ Dernovšek, J Hauser, N Henigsberg, W Maier, ...
Journal of psychopharmacology 28 (2), 133-141, 2014
1062014
Shared genetic factors influence head motion during MRI and body mass index
K Hodgson, RA Poldrack, JE Curran, EE Knowles, S Mathias, ...
Cerebral Cortex 27 (12), 5539-5546, 2017
752017
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables
R Iniesta, K Hodgson, D Stahl, K Malki, W Maier, M Rietschel, O Mors, ...
Scientific reports 8 (1), 1-9, 2018
682018
Ambulatory care-sensitive conditions: their potential uses and limitations
K Hodgson, SR Deeny, A Steventon
BMJ quality & safety 28 (6), 429-433, 2019
632019
Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: meta-analysis of three treatment cohorts
J Ward, N Graham, RJ Strawbridge, A Ferguson, G Jenkins, W Chen, ...
PloS one 13 (9), e0203896, 2018
602018
Functional polymorphism in the brain‐derived neurotrophic factor gene interacts with stressful life events but not childhood maltreatment in the etiology of depression
GW Brown, TKJ Craig, TO Harris, J Herbert, K Hodgson, KE Tansey, ...
Depression and anxiety 31 (4), 326-334, 2014
552014
Exploring the role of drug-metabolising enzymes in antidepressant side effects
K Hodgson, KE Tansey, R Uher, MZ Dernovšek, O Mors, J Hauser, ...
Psychopharmacology 232, 2609-2617, 2015
522015
Identifying the common genetic basis of antidepressant response
O Pain, K Hodgson, V Trubetskoy, S Ripke, VS Marshe, MJ Adams, ...
Biological psychiatry global open science 2 (2), 115-126, 2022
452022
Approach–avoidance processes contribute to dissociable impacts of risk and loss on choice
ND Wright, M Symmonds, K Hodgson, THB Fitzgerald, B Crawford, ...
Journal of Neuroscience 32 (20), 7009-7020, 2012
432012
Genetic comorbidity between major depression and cardio‐metabolic traits, stratified by age at onset of major depression
SP Hagenaars, JRI Coleman, SW Choi, H Gaspar, MJ Adams, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 183 …, 2020
422020
The genetic basis of the comorbidity between cannabis use and major depression
K Hodgson, L Almasy, EEM Knowles, JW Kent Jr, JE Curran, TD Dyer, ...
Addiction 112 (1), 113-123, 2017
402017
Genome-wide significant loci for addiction and anxiety
K Hodgson, L Almasy, EEM Knowles, JW Kent, JE Curran, TD Dyer, ...
European Psychiatry 36, 47-54, 2016
392016
Cannabis use, depression and self‐harm: phenotypic and genetic relationships
K Hodgson, JRI Coleman, SP Hagenaars, KL Purves, K Glanville, ...
Addiction 115 (3), 482-492, 2020
372020
Childhood maltreatment and adult medical morbidity in mood disorders: comparison of unipolar depression with bipolar disorder
GM Hosang, HL Fisher, K Hodgson, B Maughan, AE Farmer
The British Journal of Psychiatry 213 (5), 645-653, 2018
322018
Adult social care and COVID-19: Assessing the impact on social care users and staff in England so far
K Hodgson
Health Foundation, 2020
282020
Epigenetic age acceleration assessed with human white-matter images
K Hodgson, MA Carless, H Kulkarni, JE Curran, E Sprooten, EE Knowles, ...
Journal of Neuroscience 37 (18), 4735-4743, 2017
282017
Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study
K Hodgson, R Uher, AA Crawford, G Lewis, MC O’Donovan, R Keers, ...
Journal of psychopharmacology 28 (2), 142-150, 2014
272014
The genetic basis of depression
K Hodgson, P McGuffin
Behavioral Neurobiology of Depression and Its Treatment, 81-99, 2013
272013
Inferring pathobiology from structural MRI in schizophrenia and bipolar disorder: modeling head motion and neuroanatomical specificity
N Yao, AM Winkler, J Barrett, GA Book, T Beetham, R Horseman, O Leach, ...
Human brain mapping 38 (8), 3757-3770, 2017
262017
Transcriptomics and the mechanisms of antidepressant efficacy
K Hodgson, KE Tansey, TR Powell, G Coppola, R Uher, MZ Dernovšek, ...
European Neuropsychopharmacology 26 (1), 105-112, 2016
262016
The system can't perform the operation now. Try again later.
Articles 1–20